◆英語タイトル:Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2999
◆発行会社(調査会社):
GlobalData
◆発行日:2018年8月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Nipro Corp (8086) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It also offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Osaka, Japan.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Nipro Corp – Key Facts 6
Nipro Corp – Key Employees 7
Nipro Corp – Major Products and Services 8
Nipro Corp – History 11
Nipro Corp – Company Statement 13
Nipro Corp – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Joint Venture 16
Section 2 – Company Analysis 17
Company Overview 17
Nipro Corp – Business Description 18
Business Segment: Medical-Related segment 18
Overview 18
Performance 18
Business Segment: Other segment 18
Overview 18
Performance 18
Business Segment: Pharma Packaging segment 18
Overview 18
Performance 18
Business Segment: Pharmaceutical-Related segment 19
Overview 19
Performance 19
Geographical Segment: America 19
Performance 19
Geographical Segment: Asia 19
Performance 19
Geographical Segment: Europe 19
Performance 19
Geographical Segment: Japan 19
Performance 19
R&D Overview 19
Nipro Corp – Corporate Strategy 20
Nipro Corp – SWOT Analysis 21
SWOT Analysis – Overview 21
Nipro Corp – Strengths 21
Nipro Corp – Weaknesses 22
Nipro Corp – Opportunities 23
Nipro Corp – Threats 24
Nipro Corp – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
Nipro Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 34
Nipro Corp, Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Feb 02, 2017: SMT appoints EUKON as strategic partner in Italy 36
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Nipro Corp, Key Facts 6
Nipro Corp, Key Employees 7
Nipro Corp, Major Products and Services 8
Nipro Corp, History 11
Nipro Corp, Other Locations 14
Nipro Corp, Subsidiaries 14
Nipro Corp, Joint Venture 16
Nipro Corp, Key Competitors 25
Nipro Corp, Ratios based on current share price 26
Nipro Corp, Annual Ratios 27
Nipro Corp, Annual Ratios (Cont...1) 28
Nipro Corp, Annual Ratios (Cont...2) 29
Nipro Corp, Interim Ratios 31
Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
Nipro Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 34
Nipro Corp, Recent Deals Summary 35
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40
List of Figures
Nipro Corp, Performance Chart (2014 - 2018) 30
Nipro Corp, Ratio Charts 32
Nipro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 33
Nipro Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 34